|Articles|October 16, 2020

Characterization of Nano-Pharmaceuticals with FFF-MALS-DLS

FFF-MALS-DLS provides the detailed characterization of nano-pharmaceuticals that is essential for development and regulatory filing.

Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.

Subscribe Now!

Trending on LCGC International

Characterization of Nano-Pharmaceuticals with FFF-MALS-DLS

Newsletter

Related Content

The What, How, and Why of PFAS in Food Testing: Today’s Challenges and Tomorrow’s Expectations

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 4: Application to Fish and Other Animal Tissue Samples

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 3: Application to Sand, Soil, Sediment, Sludge, Biosolid and Other Solid Samples

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 2: Application to Surface Water and Wastewater Samples

Analysis of 40 Per- and Polyfluoroalkyl Substances by US EPA Method 1633 Part 1: Method Development and Verification with Quality Control Samples

Trending on LCGC International

Thermo Fisher and NVIDIA Partner to Expand AI Driven Laboratory Automation

Isotope Dilution HPLC–MS/MS Analysis of Serum Cotinine Reveals Environmental Tobacco Smoke–Associated PID Risk

Waters Corporation Shareholders Approve Share Issuance for Planned Combination with BD Biosciences and Diagnostics

Rapid Native HIC–MS Using Ammonium Tartrate for Robust Drug-to-Antibody Ratio Characterization of Antibody–Drug Conjugates

Best of the Week: Antibody–Drug Conjugates, Corneal Proteomics